drugset / Trial / NCT01192854
An Study of Efficacy and Safety of Clevudine
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Randomized, double blind parallel group, positive control, multi-center trial. Patients will be randomized at 1:1 ratio in group A or group B
Timeline
- Start
- 2010-02
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Adefovir | Unknown | 10 mg | — |
| Subject | Clevudine | Small molecule | 30 mg | — |